AlzChem Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

AlzChem Group şirketinin toplam hissedar öz sermayesi €192.5M ve toplam borcu €0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla €480.2M ve €287.7M dir. AlzChem Group 'in FAVÖK'ü €74.1M faiz karşılama oranı 28.2 dur. Şirketin €40.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

€0

Borç

Faiz karşılama oranı	28.2x
Nakit	€40.62m
Eşitlik	€192.49m
Toplam yükümlülükler	€287.70m
Toplam varlıklar	€480.18m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ACT 'nin kısa vadeli varlıkları ( €266.2M ) kısa vadeli yükümlülüklerini ( €114.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: ACT şirketinin kısa vadeli varlıkları ( €266.2M ) uzun vadeli yükümlülüklerini ( €173.1M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ACT borçsuzdur.

Borcun Azaltılması: ACT un 5 yıl önce borcu yoktu.

Borç Kapsamı: ACT un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: ACT şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

AlzChem Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: €1.22 (vs €0.85 in 3Q 2023)

AlzChem Group AG to Report Fiscal Year 2024 Results on Feb 28, 2025

Price target increased by 13% to €71.78

Price target increased by 7.7% to €66.03

Investor sentiment improves as stock rises 20%

Now 23% overvalued

Investor sentiment deteriorates as stock falls 16%

Price target increased by 13% to €61.30

Price target increased by 7.5% to €56.05

Second quarter 2024 earnings released: EPS: €0.71 (vs €0.70 in 2Q 2023)

AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024

Price target increased by 9.4% to €54.05

New minor risk - Share price stability

Price target increased by 15% to €49.40

AlzChem Group AG to Report First Half, 2024 Results on Aug 01, 2024

First quarter 2024 earnings released: EPS: €1.20 (vs €0.76 in 1Q 2023)

Investor sentiment improves as stock rises 17%

Dividend increased to €1.20

AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024

Price target increased by 7.9% to €37.35

Price target increased by 7.9% to €35.60

Price target increased by 9.1% to €34.63

AlzChem Group AG to Report Q1, 2024 Results on Apr 30, 2024

Price target increased by 9.3% to €33.00

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: €0.85 (vs €0.58 in 3Q 2022)

AlzChem Group AG to Report Fiscal Year 2023 Results on Mar 01, 2024

AlzChem Group AG to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment improves as stock rises 17%

New minor risk - Financial position

Second quarter 2023 earnings released: EPS: €0.71 (vs €0.95 in 2Q 2022)

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG to Report First Half, 2023 Results on Aug 03, 2023

Upcoming dividend of €1.05 per share at 5.5% yield

Price target increased by 8.7% to €29.58

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improved over the past week

AlzChem Group AG, Annual General Meeting, May 11, 2023

Price target decreased to €26.05

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG to Report Fiscal Year 2022 Final Results on Feb 28, 2023

Price target decreased to €26.05

AlzChem Group AG provides sales guidance For the fiscal year 2022

Second quarter 2022 earnings released: EPS: €0.95 (vs €0.90 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG Approves Dividend

Upcoming dividend of €1.00 per share

AlzChem Group AG Increasing Its Sales Forecast for the Fiscal Year 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

AlzChem Group AG Proposes Dividend for the Year 2021

Third quarter 2021 earnings released: EPS €0.46 (vs €0.37 in 3Q 2020)

Price target increased to €32.25

Second quarter 2021 earnings released: EPS €0.66 (vs €0.66 in 2Q 2020)

AlzChem Group AG Revises Earnings Guidance for the Year 2021

AlzChem Group AG Resolves Dividend, Payable on May 18, 2021

First quarter 2021 earnings released

Upcoming dividend of €0.77 per share

AlzChem Group AG Revises Earnings Guidance for 2021

Full year 2020 earnings released: EPS €1.94 (vs €1.77 in FY 2019)

AlzChem Group AG Provides Consolidated Sales Guidance for the Full Year 2021

AlzChem Group AG Proposes Dividend for 2020

New 90-day high: €24.50

AlzChem Group AG to Report Fiscal Year 2020 Results on Mar 19, 2021

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: EPS €0.37

AlzChem Group AG Expands Nitrile Production by 50%

New 90-day low: €17.50

AlzChem Group AG Revises Consolidated Sales Guidance for the Fiscal Year 2020

AlzChem Group AG to Report First Half, 2021 Results on Aug 05, 2021

AlzChem Group AG to Report Q1, 2021 Results on May 06, 2021

Price target raised to €28.50

New 90-day high - €22.70

Earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi